...
机译:一种新的HLA-B变体,HLA-B * 14:02:16 HLA-B * 14:02:16,由基于扩增子的下一代测序发现
Institute for Transplantation Diagnostics and Cell TherapeuticsUniversity Hospital of;
Institute for Transplantation Diagnostics and Cell TherapeuticsUniversity Hospital of;
Institute for Transplantation Diagnostics and Cell TherapeuticsUniversity Hospital of;
Institute for Transplantation Diagnostics and Cell TherapeuticsUniversity Hospital of;
next‐generation sequencing; novel HLA‐B allele; synonymous variation;
机译:一种新的HLA-B变体,HLA-B * 14:02:16 HLA-B * 14:02:16,由基于扩增子的下一代测序发现
机译:HLA-A * 11:01:01:16,-B * 15:548,-DPA1 * 02:02:02:06Q,-DPA1 * 02:02:08 HLA-A * 11:01:01:16, -B * 15:548,-DPA1 * 02:02:02:06Q,-DPA1 * 02:02:08和-DPA1 * 02:25 -DPA1 * 02:25,在中国蒙古人确定
机译:新型HLA-A * 24:02 HLA-A * 24:02变体,HLA-A * 24:02:56 HLA-A * 24:02:56,通过在中国个人中测序鉴定
机译:16(14)微米在02 {sup} 00(10 {sup} 00)-01 {sup} 10和02 {sup} 01(10 {sup} 01)-01 {sup 11乐队
机译:宫颈癌或癌症患者中HPV-16 E7 HLA-DR限制性表位的鉴定和功能分析。
机译:HLA-DQB1 * 02 –受限制的HPV-16 E7肽特异性CD4 + T细胞免疫反应与HPV-16伴发的高度鳞状上皮内病变的消退相关
机译:无关造血SCT中HLA-DRB1 * 14:01 / * 14:54和HLA-DRB3 * 02:01 / * 02:02的难题